Alia Therapeutics

Trento, Italy

Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.

$4.8M raised

Apr 2023

Seed

Biotechnology Therapeutics

Top Investors

Sofinnova Partners Indaco Venture Partners BiovelocITA Trentino Invest Srl

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Alia Therapeutics

How much funding has Alia Therapeutics raised?

Alia Therapeutics has raised $4.8M in total funding. The most recent round was Seed. The last funding was announced in April 2023.

Who are Alia Therapeutics's investors?

Alia Therapeutics's investors include Sofinnova Partners, Indaco Venture Partners, BiovelocITA, Trentino Invest Srl.

Where is Alia Therapeutics headquartered?

Alia Therapeutics is headquartered in Trento, Italy.

What does Alia Therapeutics do?

Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.

What stage is Alia Therapeutics at?

Alia Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 17, 2023.

MLA

"Alia Therapeutics — Funding & Investors." VCBacked, April 17, 2023, https://www.vcbacked.co/company/alia-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2023). Alia Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/alia-therapeutics

Wikipedia (cite web)

{{cite web |title=Alia Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/alia-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 17, 2023.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K